Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Adrenergic Beta-Antagonists and Agmatine

Research Papers that Mention the Interaction

Interestingly, the anticonvulsant effects of these effective combinations of lithium and agmatine were prevented by pre-treatment with low and non-effective doses of yohimbine [ α(2)-adrenoceptor antagonist ] (0.1 and 0.5mg/kg).
European journal of pharmacology  •  2011  |  View Paper
agmatine (… beta-adrenergic receptor antagonist/5-HT1A/1B receptor antagonist pindolol (20 mg x kg(-1), ip), alpha2-adrenergic receptor antagonists yohimbine (5-10 mg x kg(-1), ip) or …-20 mg x kg(-1), ip) and 5-HT3 receptor antagonist tropisetron (5-40 mg x kg(-1), ip).
Yao xue xue bao = Acta pharmaceutica Sinica  •  2008  |  View Paper
Concurrent infusion of agmatine with the cADPR blocker 8-bromo-cADPR (2 microM) prevents the increase in filtration rate.
American journal of physiology. Renal physiology  •  2008  |  View Paper
a beta-adrenoceptor antagonist ), prevented the effect of agmatine (10 mg/kg, i.p.)
Brain Research  •  2004  |  View Paper
In conclusion, the … data indicate that agmatine both acts as an antagonist at the ligand recognition site of the α2D‐adrenoceptor and enhances the effects of α2‐adrenoceptor agonists probably by binding to an allosteric binding site of the α2D‐adrenoceptor which seems to be labelled by [14C]‐agmatine.
British journal of pharmacology  •  2000  |  View Paper